The gel can be safely used for patients above 9 years of age
Glenmark Pharmaceuticals has launched India’s first topical Minocycline 4 per cent gel for the treatment of moderate to severe acne, under the brand name MINYM. This is a potent anti-bacterial gel which exerts a strong anti-inflammatory action It also offers the lowest MIC90 (minimum Inhibitory Concentration at which it stops/prevents visible growth of 90 per cent of isolates of bacteria) compared to the available topical antibacterial formulations.
MINYM Gel (Topical Minocycline 4 per cent gel) has been developed to address these growing concerns in the treatment of acne and is safe to use in patients above nine years of age.
Alok Malik, Group Vice President & Head, India Formulations –
Glenmark said, “Glenmark is a leader in the dermatology segment in India and has been at the forefront in providing access to the latest treatment options to the patients. We are proud to introduce the first topical Minocycline-based – MINYM Gel, in India; proven for its potent anti-bacterial effect, anti-inflammatory action and lowest resistance, as a treatment option to patients aged nine years and above suffering from acne.”
